News Sentiment

GALT sentiment intelligence

Galectin Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.18 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+2.8% over one week, +47.8% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Galectin Therapeutics CMO Jamil Khurram sells $83,284 in stock

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction 2.8% Price confirming higher
Trend fit Trend active 47.8% over four weeks
Fair value 58.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 35
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 10
Market source 7
TradingView 6
Investing.com 5
GlobeNewswire 4
Investing.com South Africa 2
www.marketscreener.com 2
marketscreener.com 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 14
Analyst action 2
Macro sensitivity 1
Deals and strategy 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49